Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
Author Information
Author(s): Ween Miranda P., Oehler Martin K., Ricciardelli Carmela
Primary Institution: University of Adelaide
Hypothesis
The study investigates the roles of extracellular matrix components, specifically versican, hyaluronan, and CD44, in ovarian cancer metastasis.
Conclusion
Versican, hyaluronan, and CD44 are critical in promoting ovarian cancer metastasis and may serve as potential therapeutic targets.
Supporting Evidence
- High levels of hyaluronan are associated with reduced overall survival in ovarian cancer patients.
- CD44 expression is linked to ovarian cancer cell adhesion and metastasis.
- Versican levels correlate with tumor progression and poor patient outcomes in ovarian cancer.
Takeaway
This study looks at how certain substances in the body help ovarian cancer spread, and suggests that targeting these substances could help treat the cancer.
Methodology
The review summarizes existing studies on the roles of versican, hyaluronan, and CD44 in ovarian cancer progression and metastasis.
Limitations
The review is based on existing literature and may not include all relevant studies or data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website